| The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential … A Heinze, B Grebe, M Bremm, S Huenecke, TA Munir, L Graafen, ... Frontiers in immunology 10, 2816, 2019 | 46 | 2019 |
| Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children M Merker, V Pfirrmann, S Oelsner, S Fulda, T Klingebiel, WS Wels, ... Oncotarget 8 (39), 66137, 2017 | 40 | 2017 |
| Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first … E Rettinger, S Huenecke, H Bonig, M Merker, A Jarisch, J Soerensen, ... Haematologica 101 (4), e153, 2016 | 37 | 2016 |
| Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience AM Willasch, E Salzmann-Manrique, T Krenn, M Duerken, J Faber, ... Bone Marrow Transplantation 52 (2), 201-208, 2017 | 32 | 2017 |
| Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation E Rettinger, M Merker, E Salzmann-Manrique, H Kreyenberg, T Krenn, ... Biology of blood and marrow transplantation 23 (1), 87-95, 2017 | 32 | 2017 |
| Pediatric ICU admissions after adolescent suicide attempts during the pandemic N Bruns, L Willemsen, A Stang, B Kowall, K Holtkamp, O Kamp, M Dudda, ... Pediatrics 150 (2), e2021055973, 2022 | 30 | 2022 |
| Clearance of hematologic malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions M Merker, E Salzmann-Manrique, V Katzki, S Huenecke, M Bremm, ... Biology of Blood and Marrow Transplantation 25 (7), 1281-1292, 2019 | 30 | 2019 |
| Undesired side effects of tapentadol in comparison to oxycodone: A meta-analysis of randomized controlled comparative studies M Merker, G Dinges, T Koch, P Kranke, AM Morin Der Schmerz 26, 16-26, 2012 | 30 | 2012 |
| ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma M Merker, J Wagner, H Kreyenberg, C Heim, LM Moser, WS Wels, ... Frontiers in immunology 11, 581468, 2020 | 24 | 2020 |
| Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated … E Rettinger, H Kreyenberg, M Merker, S Kuçi, A Willasch, G Bug, E Ullrich, ... Cytotherapy 16 (6), 835-844, 2014 | 24 | 2014 |
| Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus V Pfirrmann, S Oelsner, E Rettinger, S Huenecke, H Bonig, M Merker, ... Cytotherapy 17 (8), 1139-1151, 2015 | 22 | 2015 |
| Improving clinical manufacturing of IL-15 activated cytokine-induced killer (CIK) cells M Bremm, LM Pfeffermann, C Cappel, V Katzki, S Erben, S Betz, ... Frontiers in immunology 10, 1218, 2019 | 21 | 2019 |
| Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu Oxycodon M Merker, G Dinges, T Koch, P Kranke, AM Morin Der Schmerz 1 (26), 16-26, 2012 | 13 | 2012 |
| Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial M Merker, MT Meister, E Rettinger, A Jarisch, J Soerensen, A Willasch, ... Bone Marrow Transplantation 53 (7), 891-894, 2018 | 11 | 2018 |
| Prophylaxis of nausea and vomiting in the postoperative phase: relative effectiveness of droperidol and metoclopramide M Merker, P Kranke, AM Morin, D Rüsch, LHJ Eberhart Der Anaesthesist 60, 432-445, 2011 | 11 | 2011 |
| Impact of the First COVID Lockdown on Accident-and Injury-Related Pediatric Intensive Care Admissions in Germany—A Multicenter Study N Bruns, LY Willemsen, K Holtkamp, O Kamp, M Dudda, B Kowall, ... Children 9 (3), 363, 2022 | 9 | 2022 |
| Retargeting of nk-92 cells against high-risk rhabdomyosarcomas by means of an erbb2 (Her2/neu)-specific chimeric antigen receptor LDH Gossel, C Heim, LM Pfeffermann, LM Moser, HB Bönig, ... Cancers 13 (6), 1443, 2021 | 9 | 2021 |
| AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation? S Bakhtiar, E Salzmann-Manrique, M Hutter, T Krenn, M Duerken, J Faber, ... Bone Marrow Transplantation 54 (5), 737-745, 2019 | 8 | 2019 |
| No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease U Thiel, SJ Schober, A Ranft, H Gassmann, S Jabar, K Gall, ... Bone Marrow Transplantation 56 (7), 1550-1557, 2021 | 7 | 2021 |
| Trends in accident-related admissions to pediatric intensive care units during the first COVID-19 lockdown in Germany N Bruns, L Willemsen, K Holtkamp, O Kamp, M Dudda, B Kowall, A Stang, ... medRxiv, 2021.08. 06.21261728, 2021 | 5 | 2021 |
